Articles published in Journal of Bioequivalence & Bioavailability have been cited by esteemed scholars and scientists all around the world. Journal of Bioequivalence & Bioavailability has got h-index 26, which means every article in Journal of Bioequivalence & Bioavailability has got 26 average citations.
Following are the list of articles that have cited the articles published in Journal of Bioequivalence & Bioavailability.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
60 | 61 | 19 | 6 | 27 |
Year wise citations received |
394 | 412 | 405 | 380 | 363 |
Journal total citations count | 4363 |
Journal Impact Factor | 6.89 |
Journal 5 years Impact Factor | 11.60 |
Journal CiteScore | 14.43 |
Journal h-index | 26 |
Franke RM, Morton T, Devarakonda K (2015) Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug design, development and therapy, 9: 4587.
Morton TL, Devarakonda K, Kostenbader K, Montgomery J, Barrett T, et al. (2015) Correlation of Subjective Effects with Systemic Opioid Exposure from Fixed-Dose Combinations of Oxycodone/Acetaminophen in Recreational Users of Prescription Drugs. Pain Medicine, pme12884.
Devarakonda K, Kostenbader K, Giuliani MJ, Young JL (2015) Single-and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen. Journal of pain research, 8: 647.
Singla N, Margulis R, Kostenbader K, Zheng Y, Barrett T, et al. (2015) Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain. The Physician and sportsmedicine, 43: 126-137.
Singla N, Barrett T, Sisk L, Kostenbader K, Young J (2014) Assessment of the safety and efficacy of extended-release oxycodone/acetaminophen, for 14 days postsurgery. Current medical research and opinion, 30: 2571-2578.
Devarakonda K, Morton T, Margulis R, Giuliani M, Barrett T (2014) Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer, biphasic, IR/ER combination formulation, under fed and fasted conditions. Drug Des Devel Ther, 8: 1125-1134.
Shabana MD Research and Reviews: Journal of Pharmacology and Toxicological Studies.
Bekhit MH (2015) Profile of extended-release oxycodone/acetaminophen for acute pain. Journal of pain research, 8: 719.
Morton TL, Devarakonda K, Kostenbader K, Montgomery J, Barrett T, et al. (2015) Correlation of Subjective Effects with Systemic Opioid Exposure from Fixed-Dose Combinations of Oxycodone/Acetaminophen in Recreational Users of Prescription Drugs. Pain Medicine, pme12884.
Devarakonda K, Kostenbader K, Giuliani MJ, Young JL (2015) Single-and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen. Journal of pain research, 8: 647.
Singla N, Margulis R, Kostenbader K, Zheng Y, Barrett T, et al. (2015) Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain. The Physician and sportsmedicine, 43: 126-137.
Singla N, Barrett T, Sisk L, Kostenbader K, Young J (2014) Assessment of the safety and efficacy of extended-release oxycodone/acetaminophen, for 14 days postsurgery. Current medical research and opinion, 30: 2571-2578.
Devarakonda K, Morton T, Margulis R, Giuliani M, Barrett T (2014) Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer, biphasic, IR/ER combination formulation, under fed and fasted conditions. Drug Des Devel Ther, 8: 1125-1134.
Amrutha JV (2016) Pre and Post Compression Studies of Tablets. Inorganic Chemistry: An Indian Journal, 11(3).
Zaman M, Adnan S, Farooq M, Aun A, Yousaf MU, et al. (2016) A Comprehensive Review on Bioequivalence Studies in Human Subjects. British Journal of Pharmaceutical Research, 11(2).
Elzanfaly ES, Merey HA (2017) A Liquid Chromatography/Tandem Mass Spectrometric Method for Determination of Captopril in Human Plasma: Application to a Bioequivalence Study. Journal of Applied Pharmaceutical Science Vol, 7: 008-015.
Amrutha JV (2016) Pre and Post Compression Studies of Tablets. Inorganic Chemistry: An Indian Journal, 11(3).
Kittana N, Hattab S, Ziyadeh-Isleem A, Jaradat N, Zaid AN (2016) Montelukast, current indications and prospective future applications. Expert Review of Respiratory Medicine, 10: 943-956.
Zaid AN, Abualhasan MN, Watson DG, Mousa A, Ghazal N, et al. (2015) Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method. Drug design, development and therapy, 9: 5315.
Zaid AN, Mousa A, Ghazal N, Bustami R (2015) Interchangeability and comparative effectiveness between generic and brand montelukast immediate release tablets after a single oral administration in healthy volunteers. Clinical and translational allergy, 5: 37.